Professor David Price
Chair of Primary Care Respiratory Med
- 黑料网
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 6 of 20 Results 251 to 300 of 976
Dupilumab Treatment Leads to Sustained Reductions in Oral Corticosteroid Use in Patients With Oral Corticosteroid-Dependent Severe Asthma
CHEST 2022, pp. A1909-A1913Contributions to Journals: Abstracts- [ONLINE]
- [ONLINE] DOI:
- [OPEN ACCESS]
Characterization of patients in the International Severe Asthma Registry with high steroid exposure who did or did not initiate biologic therapy
Journal of Asthma and Allergy, vol. 15, no. 15, pp. 1491鈥�1510Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
AMCP Nexus 2022Contributions to Conferences: AbstractsClinical outcomes in patients with severe asthma who had or had not initiated biologic therapy: results from the CLEAR study
CHEST 2022, pp. A28-A32Contributions to Journals: Abstracts- [ONLINE]
- [ONLINE] DOI:
- [OPEN ACCESS]
Clinical Review: The suggested management pathway for urticaria in primary care
Clinical and Translational Allergy, vol. 12, no. 10, e12195Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Clinical outcomes and emergency healthcare utilization in patients with severe asthma who continued, switched or stopped biologic therapy: results from the CLEAR study
CHEST Annual Meeting, pp. A23-A27Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Short-acting 尾2-agonist prescription patterns for asthma management in the SABINA III primary care cohort
npj Primary Care Respiratory Medicine, vol. 32, 37Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Suboptimal peak inspiratory flow and critical inhalation errors are associated with higher COPD-related healthcare costs
International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 2401-2415Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Oral corticosteroids in asthma and beyond: moving forward
European Respiratory Journal, vol. 60, no. 3, 2200776Contributions to Journals: Editorials- [ONLINE] DOI:
- [OPEN ACCESS]
Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy
International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 2187鈥�2200Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Sociodemographic and clinical characteristics of patients with asthma who were prescribed 鈮�3 SABA canisters/year in the SABINA International study
European Respiratory Society (ERS) International Congress., pp. 2374Contributions to Conferences: Abstracts- [ONLINE]
- [OPEN ACCESS]
Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma
European Respiratory Society (ERS) International Congress., 4420Contributions to Journals: Abstracts- [ONLINE] DOI:
Sociodemographic and clinical characteristics of patients with asthma who were prescribed 鈮�3 SABA canisters/year in the SABINA International study
European Respiratory Society (ERS) International Congress., 3397Contributions to Journals: Abstracts- [ONLINE] DOI:
Mortality Analyses on Systemic Corticosteroid Use: a Long-term Observational Study
BTS Winter Meeting 2021, pp. A7-A8Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
17th Annual Deutscher Allergiekongress (DAK) 2022, pp. 212Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Eastern Pulmonary Conference 2022Contributions to Conferences: Abstracts- [ONLINE]
A pragmatic primary practice approach to using specific IgE in allergy testing in asthma diagnosis, management, and referral
Journal of Asthma and Allergy, vol. 2022, no. 15, pp. 1069鈥�1080Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Correspondence to Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus
Allergy, vol. 77, no. 8, pp. 2571-2573Contributions to Journals: Letters- [ONLINE] DOI:
- [ONLINE]
COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry
Annals of Family Medicine, vol. 20, no. 4, pp. 319-327Contributions to Journals: Articles- [ONLINE] DOI:
Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma
European Respiratory Society (ERS) International Congress.Contributions to Conferences: Abstracts- [OPEN ACCESS]
A Response to: Letter to the Editor Regarding 鈥淐linical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab鈥�
Advances in Therapy, vol. 39, no. 8, pp. 3862-3865Contributions to Journals: Letters- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Aspen Allergy Conference 鈥� 40th MeetingContributions to Conferences: AbstractsPersistent OCS reduction regardless of starting OCS dose in patients with severe, OCS-dependent asthma treated with dupilumab: LIBERTY ASTHMA TRAVERSE study
15潞 Congreso ALAT 2022Contributions to Conferences: AbstractsCharacterisation of the Australian adult population living with asthma: Severe exacerbation frequency, long-term OCS use and adverse effects.
Pragmatic and Observational Research, vol. 2022, pp. 43-58Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Healthcare resource utilisation associated with intermittent oral corticosteroid use in asthma
EAACI HYBRID CONGRESS 2022Contributions to Conferences: Abstracts- [ONLINE]
Biologics in severe asthma: the role of real-world evidence from registries
European Respiratory Review, vol. 31, no. 164, 210278Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
2022 AANP National ConferenceContributions to Conferences: PostersLet鈥檚 improve COPD prognosis: a practical tool for primary care providers to identify the frequency and follow-up of COPD lung attacks
Dutch Lung Congress 2022Contributions to Conferences: AbstractsReply to: Cause or consequence?
European Respiratory Journal, vol. 59, no. 6, 2200103Contributions to Journals: Comments and Debates- [ONLINE] DOI:
- [OPEN ACCESS]
- [OPEN ACCESS]
Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial
The Lancet. Respiratory medicine, vol. 10, no. 6, pp. 584-592Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Reducci贸n persistente de corticosteroides orales independientemente de la dosis basal, en pacientes con asma c贸rtico-dependiente tratados con dupilumab: Estudio Liberty Asthma-Traverse
55 Congreso Separ, pp. 75Contributions to Journals: Abstracts- [ONLINE]
- [ONLINE]
- [ONLINE]
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
The 35th annual
Eastern Allergy Conference, pp. S9Contributions to Conferences: Abstracts- [ONLINE]
- [ONLINE]
Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global Perspective
Advances in Therapy, vol. 39, pp. 2302鈥�2322Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Treatment guided by fractional exhaled nitric oxide in addition to standard care in 6- to 15-year-olds with asthma: the RAACENO RCT
Efficacy and Mechanism Evaluation, vol. 9, no. 4Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers
npj Primary Care Respiratory Medicine, vol. 32, no. 1, 18Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Evaluation of critical inhalation technique errors in patients with COPD on Dry Powder Inhaler maintenance therapy based on their association with health status: findings from the PIFotal study.
IPCRG 2022Contributions to Conferences: Abstracts- [ONLINE]
Short-acting 尾2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study
European Respiratory Journal, vol. 59, no. 5Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Suboptimal peak inspiratory flow and inhalation technique errors are associated with higher COPD-relateD healthcare costs: results from the PIFotal COPD study
IPCRG 2022Contributions to Conferences: Abstracts- [ONLINE]
The burden of intermittent oral corticosteroid use in asthma
IPCRG 2022Contributions to Conferences: Abstracts- [ONLINE]
Adverse Outcomes Post-initiation of Systemic Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease: A Long-term Observational UK-based Study
ATS 2022Contributions to Journals: Abstracts- [ONLINE] DOI:
Clinical Remission in Severe Asthma: A Pooled Post hoc Analysis of the Patient Journey with Benralizumab
Advances in Therapy, vol. 39, no. 5, pp. 2065鈥�2084Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Impact of initiating biologics in patients with severe asthma and on long-term oral corticosteroids or rescue steroids (GLITTER)
ATS 2022, D102Contributions to Journals: Abstracts- [ONLINE] DOI:
Persistent Reductions in OCS Use in Patients with Severe, OCS-Dependent Asthma Treated with Dupilumab: LIBERTY ASTHMA TRAVERSE Study
ATS 2022, A2365Contributions to Journals: Abstracts- [ONLINE] DOI:
Predicting Pneumonia events in COPD patients using medical records
ATS 2022Contributions to Journals: Abstracts- [ONLINE] DOI:
Prevalence of comorbidities in adults with severe asthma: results from the International Severe Asthma Registry (ISAR)
ATS 2022Contributions to Journals: Abstracts- [ONLINE] DOI:
Prototype ORACLE Score Validation in NOVELTY: Predicted versus Observed Asthma Exacerbation Rates
ATS 2022, A486Contributions to Journals: Abstracts- [ONLINE] DOI:
Relationships Between Symptoms and Lung Function in Asthma and/or Chronic Obstructive Pulmonary Disease in the NOVELTY study
ATS 2022, A4013Contributions to Journals: Abstracts- [ONLINE] DOI:
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma
The Journal of Allergy and Clinical Immunology: In Practice, vol. 10, no. 5Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [OPEN ACCESS]
Variation in demographic and clinical characteristics of Patients with COPD receiving care in U.S. primary care: data from the Advancing the Patient EXperience (APEX) in COPD registry
Pragmatic and Observational Research, vol. 2022, no. 13, pp. 17-31Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial. (BICS)
Trials, vol. 23, no. 1, 307Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]